Literature DB >> 16120440

Radiation response and cell cycle regulation of p53 rescued malignant keratinocytes.

Maarten Niemantsverdriet1, Wim Jongmans, Claude Backendorf.   

Abstract

Mutations in the tumor suppressor gene p53 were found in more than 90% of all human squamous cell carcinomas (SCC). To study the function of p53 in a keratinocyte background, a tetracycline-controlled p53 transgene was introduced into a human SCC cell line (SCC15), lacking endogenous p53. Conditional expression of wild-type p53 protein upon withdrawal of tetracycline was accompanied with increased expression of p21(WAF1/Cip1) resulting in reduced cell proliferation. Flow-cytometric analysis revealed that these cells were transiently arrested in the G1/S phase of the cell cycle. However, when SCC15 cells expressing p53 were exposed to ionizing radiation (IR), a clear shift from a G1/S to a G2/M cell cycle arrest was observed. This effect was greatly depending on the presence of wild-type p53, as it was not observed to the same extent in SCC15 cells lacking p53. Unexpectedly, the p53- and IR-dependent G2/M cell cycle arrest in the keratinocyte background was not depending on increased expression or stabilization of 14-3-3sigma, a p53-regulated effector of G2/M progression in colorectal cancer cells. In keratinocytes, 14-3-3sigma (stratifin) is involved in terminal differentiation and its cell cycle function in this cell type might diverge from the one it fulfills in other cellular backgrounds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120440     DOI: 10.1016/j.yexcr.2005.07.016

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

1.  ΔNp73 enhances promoter activity of TGF-β induced genes.

Authors:  Maarten Niemantsverdriet; Peter Nagle; Roland K Chiu; Johannes A Langendijk; Harm H Kampinga; Robert P Coppes
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

2.  Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinoma.

Authors:  Yusei Fujita; Itsuro Kato; Soichi Iwai; Koji Ono; Minoru Suzuki; Yoshinori Sakurai; Ken Ohnishi; Takeo Ohnishi; Yoshiaki Yura
Journal:  Radiat Oncol       Date:  2009-12-11       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.